Results 111 to 120 of about 789 (171)

Unintentional periconceptional exposure to glucagon‐like peptide‐1 receptor agonists and adverse pregnancy outcomes: A nationwide cohort study in Taiwan

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1420-1430, February 2026.
Abstract Aims To assess whether periconceptional exposure to glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) is associated with adverse outcomes in women with pregestational type 2 diabetes. Materials and Methods We linked Taiwan's Birth Certificate Application and National Health Insurance claims (2013–2022) to assemble a nationwide cohort of ...
Yi‐Chang Chou   +5 more
wiley   +1 more source

Fetal Growth Outcomes in Early Gestational Diabetes Mellitus Managed Immediately After Diagnosis

open access: yesJournal of Obstetrics and Gynaecology Research, Volume 52, Issue 2, February 2026.
ABSTRACT Aim To evaluate fetal growth outcomes in gestational diabetes diagnosed before 20 weeks' gestation (E‐GDM) following immediate intervention and to identify factors associated with abnormal fetal growth. Methods We retrospectively analyzed singleton term pregnancies with E‐GDM between 2016 and 2021 at two university hospitals in Japan: Keio ...
Sayuri Nakanishi   +8 more
wiley   +1 more source

Risk Factors in the First 1000 Days of Life Associated With Childhood Obesity: A Systematic Review and Risk Factor Quality Assessment

open access: yesObesity Reviews, Volume 27, Issue 2, February 2026.
ABSTRACT Background Early‐life exposures might negatively affect fetal and infant development, predisposing children to obesity. This study aimed to systematically identify and evaluate risk factors for childhood obesity in preconception, pregnancy, and infancy, and assess their potential for future prediction and prevention strategies.
Sophia M. Blaauwendraad   +12 more
wiley   +1 more source

Maternal factors associated with fetal macrosomia

open access: yesJournal of the Chinese Medical Association, 2023
Chia-Hao, Liu   +2 more
openaire   +2 more sources

POSSIBILITIES OF CALCULATING THE RISK OF DEVELOPING MACROSOMIA IN GESTATIONAL DIABETES MELLITUS

open access: yesМать и дитя в Кузбассе
Underestimation of accelerated fetal growth during pregnancy complicated by gestational diabetes mellitus leads to short-term and long-term complications for the mother and the newborn. The work is aimed at finding factors that, at the stage of antenatal
Оксана Николаевна Новикова   +2 more
doaj  

DENTISTS VIEW ON FETAL MACROSOMIA

open access: yesWorld of Medicine and Biology, 2018
openaire   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Fetal Macrosomia

DeckerMed Obstetrics and Gynecology, 2019
Excessive fetal growth and increased birth weight are associated with significant maternal and neonatal morbidity and have become increasingly common given the global obesity epidemic.  Fetal macrosomia is traditionally defined in developed countries as fetal weight greater than 4,000 grams or 4,500 grams regardless of gestational age.
Andrea G. Edlow, Caitlin Clifford
openaire   +1 more source

Fetal Macrosomia—Animal Models

Diabetes Care, 1980
Macrosomia is characteristic of the infant whose mother has undiagnosed diabetes mellitus during pregnancy or whose diabetes has been inadequately controlled. Animal models of diabetes have included effects of pancreatectomy or beta-cell destruction by chemical agents. Maternal effects have been variable as have been effects on the fetus.
R, Schwartz, J, Susa
openaire   +2 more sources

Fetal Macrosomia and Pregnancy Outcomes

Obstetric Anesthesia Digest, 2009
Background:  Pregnancies with a macrosomic fetus comprise a subgroup of high‐risk pregnancies. There is uncertainty in the clinical management and outcomes of such pregnancies.Aim:  We sought to examine clinical management and maternal and fetal outcomes in pregnancies with macrosomic infants at Royal Brisbane and Women's Hospital (RBWH).Methods:  Data
Ju, Hong   +3 more
openaire   +3 more sources

A study of fetal macrosomia

Archives of Gynecology and Obstetrics, 1999
We describe the maternal characteristics in pregnancy with fetal macrosomia, fetal and maternal complications related to macrosomia, and the risk of impaired glucose tolerance. The study is based on a comparison of maternal and neonatal data in 956 cases of fetal macrosomia (birthweight > or =4000 g) in non-diabetic pregnancy with data in a control ...
K, Wollschlaeger   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy